Modeling the Health and Budgetary Impacts of a Team-based Hypertension Care Intervention That Includes Pharmacists
- 1 November 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Medical Care
- Vol. 57 (11) , 882-889
Abstract
Objective: The objective of this study was to assess the potential health and budgetary impacts of implementing a pharmacist-involved team-based hypertension management model in the United States. Research Design: In 2017, we evaluated a pharmacist-involved team-based care intervention among 3 targeted groups using a microsimulation model designed to estimate cardiovascular event incidence and associated health care spending in a cross-section of individuals representative of the US population: implementing it among patients with: (1) newly diagnosed hypertension; (2) persistently (≥1 year) uncontrolled blood pressure (BP); or (3) treated, yet persistently uncontrolled BP—and report outcomes over 5 and 20 years. We describe the spending thresholds for each intervention strategy to achieve budget neutrality in 5 years from a payer’s perspective. Results: Offering this intervention could prevent 22.9–36.8 million person-years of uncontrolled BP and 77,200–230,900 heart attacks and strokes in 5 years (83.8–174.8 million and 393,200–922,900 in 20 years, respectively). Health and economic benefits strongly favored groups 2 and 3. Assuming an intervention cost of $525 per enrollee, the intervention generates 5-year budgetary cost-savings only for Medicare among groups 2 and 3. To achieve budget neutrality in 5 years across all groups, intervention costs per person need to be around $35 for Medicaid, $180 for private insurance, and $335 for Medicare enrollees. Conclusions: Adopting a pharmacist-involved team-based hypertension model could substantially improve BP control and cardiovascular outcomes in the United States. Net cost-savings among groups 2 and 3 make a compelling case for Medicare, but favorable economics may also be possible for private insurers, particularly if innovations could moderately lower the cost of delivering an effective intervention.Keywords
This publication has 40 references indexed in Scilit:
- Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trialJACCP: Journal of the American College of Clinical Pharmacy, 2018
- Team-Based Care with Pharmacists to Improve Blood Pressure: a Review of Recent LiteratureCurrent Hypertension Reports, 2018
- Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid BeneficiariesAmerican Journal of Preventive Medicine, 2017
- Modeled Health and Economic Impact of Team-Based Care for HypertensionAmerican Journal of Preventive Medicine, 2016
- Economics of Team-based Care in Controlling Blood PressureAmerican Journal of Preventive Medicine, 2015
- Team-Based Care and Improved Blood Pressure ControlAmerican Journal of Preventive Medicine, 2014
- Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure ControlJAMA, 2013
- Physician and Pharmacist Collaboration to Improve Blood Pressure ControlArchives of internal medicine (1960), 2009
- A Randomized Controlled Trial of Team-Based Care: Impact of Physician-Pharmacist Collaboration on Uncontrolled HypertensionJournal of General Internal Medicine, 2008
- Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension ControlJAMA, 2008